Daniel E. Hemli

Daniel E. Hemli

Bracewell & Giuliani LLP

Contact  |  View Bio  |  RSS

Latest Posts › Patents


FTC Broadens Notification Requirements for Transfers of Pharmaceutical Patent Rights

The Federal Trade Commission (FTC) has revised the rule for determining when a transfer of exclusive rights to a patent in the pharmaceutical industry (including biologics and medicine manufacturing) results in a potentially...more

11/13/2013 - DOJ FTC Hart-Scott-Rodino Act Patents Pharmaceutical Prescription Drugs

Court Rules That Patent Infringement Can Violate Antitrust Laws

Patent infringement can be considered anticompetitive conduct under federal antitrust law, according to a recent ruling issued by the U.S. District Court for the Eastern District of Texas. ...more

9/23/2013 - Anticompetitive Agreements Antitrust Litigation Patent Infringement Patents Sherman Act

High Court Finds Antitrust Scrutiny Applies to Pay-for-Delay Settlements

On June 17, 2013, the U.S. Supreme Court determined that the Federal Trade Commission’s (FTC) antitrust challenge to a reverse payment settlement agreement between drug manufacturers, otherwise known as a “pay-for-delay”...more

6/24/2013 - Actavis Inc. FTC FTC v Actavis Generic Drugs Patents Pay-For-Delay Prescription Drugs Reverse Payment Settlement Agreements SCOTUS

3 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.